Laatste proeven

EudraCT Number: 2004-000020-32

Sponsor Protocol Number: CV131-176

Start Date: 2005-02-16

Sponsor Name: Bristol Myers Squibb International Corporation

Full Title: The Efficacy and Safety of Irbesartan/HCTZ Combination Therapy as First Line Treatment for Severe Hypertension

Medical condition: Severe Hypertension

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Completed)

Trial results: View results

EudraCT Number: 2004-001491-39

Sponsor Protocol Number: 03-0-192

Start Date: 2005-02-16

Sponsor Name: Astellas Pharma US, Inc.

Full Title: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, COMPARATIVE STUDY OF MICAFUNGIN (FK463) VERSUS CASPOFUNGIN AS ANTIFUNGAL TREATMENT IN PATIENTS WITH INVASIVE CANDIDIASIS OR CANDIDEMIA

Medical condition: Invasive candidiasis or candidemia

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.0		10042938		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: CZ (Completed) GB (Completed) BE (Completed) AT (Completed) ES (Completed)

Trial results: View results

EudraCT Number: 2004-001054-84

Sponsor Protocol Number: 2004/W/GI/02

Start Date: 2005-02-16

Sponsor Name: NHS Lothian- University Hospitals Division

Full Title: A comparison of the efficacy of dietary hydroxypropylcellulose and questran as therapeutic agents in bile acid induced diarrhoea

Medical condition: these patients will have bile acid induced diarrhoea identified by an increased serum 7a-OH-cholestenone. and will have a history of one of 1. ileal resection 2. idiopathic bile acid diarrhoea.3. ...

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2004-001854-10

Sponsor Protocol Number: BO18039

Start Date: 2005-02-16

Sponsor Name: F. Hoffmann-La Roche Ltd

Full Title: Randomized, two arm, placebo controlled double dummy study to compare the efficacy of intravenous loading doses followed by maintenance treatment with oral ibandronic acid versus zoledronic acid in...

Medical condition: Metastatic Bone Pain

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Completed) GB (Completed) DE (Prematurely Ended) IT (Prematurely Ended)

Trial results: View results

EudraCT Number: 2004-002453-31

Sponsor Protocol Number: AC-054-201

Start Date: 2005-02-15

Sponsor Name: Actelion Pharmaceuticals Ltd.

Full Title: A Phase IIb, multi-center, international, double-blind, randomized, placebo-controlled, parallel-group, dose-finding study for the prevention of cerebral vasospasm after aneurysmal subarachnoid hem...

Medical condition: Prevention of ischaemic complications related to vasospasm in patients with aneurysmal subarachnoid haemorrhage

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: AT (Completed) SE (Completed) FI (Completed) DE (Completed) IT (Completed) BE (Completed)

Trial results: View results

EudraCT Number: 2004-004633-33

Sponsor Protocol Number: bosex

Start Date: 2005-02-15

Sponsor Name: Sexological Clinic, Rigshospitalet

Full Title: local botox administration on patients with vulvar vestbulitis

Medical condition: Vulvar vestibulits

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Female

Trial protocol: DK (Completed)

Trial results: (No results available)

EudraCT Number: 2005-000290-22

Sponsor Protocol Number:

Start Date: 2005-02-15

Sponsor Name: TÜ Kardioloogiakliinik

Full Title: Endoteeli funktsiooni hindamiskompleksi (pulsilaine analüüs, koronarograafia, immunohistokeemilised meetodid, biomarkerid) teaduslik väljatöötamine ja juurutamine kliinilises praktikas

Medical condition:

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male

Trial protocol: EE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2005-000040-85

Sponsor Protocol Number: HCC01

Start Date: 2005-02-15

Sponsor Name: Medical School Hannover [...] 1. Medical School Hannover 2. Medical School Hannover

Full Title: Erbitux Monotherapie bei Patienten mit lokoregional nicht behandelbarem Hepatozellulären Karzinom

Medical condition: advanced hepatocellular carcinoma (hcc) not amandable to regional therapies or metastatic disease

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2004-003616-37

Sponsor Protocol Number: M48P3

Start Date: 2005-02-15

Sponsor Name: Chiron Behring GmbH & Co KG

Full Title: M48P3: A phase IV, randomized, controlled, single-blind, multi-center study in children to evaluate the safety, tolerability and immunogenicity of two TBE vaccines administered according to two dif...

Medical condition: TBE prophylaxis

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Infants and toddlers, Children, Under 18

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2004-003945-41

Sponsor Protocol Number: N/A

Start Date: 2005-02-15

Sponsor Name: liverpool university

Full Title: Pharmacogenetics of GABAergic mechanisms of benefit and harm in epilepsy: : A prospective cohort study to determine the enviromental and genetic factors associated with response to clobazam.

Medical condition: Epilepsy

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

Laatste proeven

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies